330 related articles for article (PubMed ID: 3501040)
1. Estrogen and oncogene mediated growth regulation of human breast cancer cells.
Kasid A; Lippman ME
J Steroid Biochem; 1987; 27(1-3):465-70. PubMed ID: 3501040
[TBL] [Abstract][Full Text] [Related]
2. Effect of v-rasH oncogene transfection on estrogen-independent tumorigenicity of estrogen-dependent human breast cancer cells.
Kasid A; Knabbe C; Lippman ME
Cancer Res; 1987 Nov; 47(21):5733-8. PubMed ID: 3664477
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
Lykkesfeldt AE; Madsen MW; Briand P
Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
[TBL] [Abstract][Full Text] [Related]
4. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
Herman ME; Katzenellenbogen BS
Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416
[TBL] [Abstract][Full Text] [Related]
5. An estrogen receptor positive MCF-7 clone that is resistant to antiestrogens and estradiol.
Jiang SY; Wolf DM; Yingling JM; Chang C; Jordan VC
Mol Cell Endocrinol; 1992 Dec; 90(1):77-86. PubMed ID: 1301400
[TBL] [Abstract][Full Text] [Related]
6. Cyr61 promotes breast tumorigenesis and cancer progression.
Tsai MS; Bogart DF; Castañeda JM; Li P; Lupu R
Oncogene; 2002 Nov; 21(53):8178-85. PubMed ID: 12444554
[TBL] [Abstract][Full Text] [Related]
7. Growth regulatory peptide production by human breast carcinoma cells.
Lippman ME; Dickson RB; Gelmann EP; Rosen N; Knabbe C; Bates S; Bronzert D; Huff K; Kasid A
J Steroid Biochem; 1988; 30(1-6):53-61. PubMed ID: 3290584
[TBL] [Abstract][Full Text] [Related]
8. Antiestrogens prevent the stimulatory effects of L-triiodothyronine on cell proliferation.
Zhou-Li F; Albaladejo V; Joly-Pharaboz MO; Nicolas B; Andre J
Endocrinology; 1992 Mar; 130(3):1145-52. PubMed ID: 1537281
[TBL] [Abstract][Full Text] [Related]
9. The paracrine stimulation of MCF-7 cells by MDA-MB-231 cells: possible role in antiestrogen failure.
Robinson SP; Jordan VC
Eur J Cancer Clin Oncol; 1989 Mar; 25(3):493-7. PubMed ID: 2703004
[TBL] [Abstract][Full Text] [Related]
10. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice.
Osborne CK; Hobbs K; Clark GM
Cancer Res; 1985 Feb; 45(2):584-90. PubMed ID: 3967234
[TBL] [Abstract][Full Text] [Related]
11. Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells.
Watts CK; Sweeney KJ; Warlters A; Musgrove EA; Sutherland RL
Breast Cancer Res Treat; 1994; 31(1):95-105. PubMed ID: 7981461
[TBL] [Abstract][Full Text] [Related]
12. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.
Bradley LM; Gierthy JF; Pentecost BT
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):185-96. PubMed ID: 18337089
[TBL] [Abstract][Full Text] [Related]
13. Induction of estrogen independence of ZR-75-1 human breast cancer cells by epigenetic alterations.
van Agthoven T; van Agthoven TL; Dekker A; Foekens JA; Dorssers LC
Mol Endocrinol; 1994 Nov; 8(11):1474-83. PubMed ID: 7533260
[TBL] [Abstract][Full Text] [Related]
14. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
Pink JJ; Jordan VC
Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
[TBL] [Abstract][Full Text] [Related]
15. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
Long BJ; Jelovac D; Thiantanawat A; Brodie AM
Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443
[TBL] [Abstract][Full Text] [Related]
16. Autocrine and paracrine growth regulation of human breast cancer.
Lippman ME; Dickson RB; Kasid A; Gelmann E; Davidson N; McManaway M; Huff K; Bronzert D; Bates S; Swain S
J Steroid Biochem; 1986 Jan; 24(1):147-54. PubMed ID: 3486321
[TBL] [Abstract][Full Text] [Related]
17. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells.
Bindels EM; Lallemand F; Balkenende A; Verwoerd D; Michalides R
Oncogene; 2002 Nov; 21(53):8158-65. PubMed ID: 12444551
[TBL] [Abstract][Full Text] [Related]
18. Estrogen-stimulation of postconfluent cell accumulation and foci formation of human MCF-7 breast cancer cells.
Gierthy JF; Lincoln DW; Roth KE; Bowser SS; Bennett JA; Bradley L; Dickerman HW
J Cell Biochem; 1991 Feb; 45(2):177-87. PubMed ID: 2055945
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.
Lee AV; Jackson JG; Gooch JL; Hilsenbeck SG; Coronado-Heinsohn E; Osborne CK; Yee D
Mol Endocrinol; 1999 May; 13(5):787-96. PubMed ID: 10319328
[TBL] [Abstract][Full Text] [Related]
20. Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells.
Lazennec G; Katzenellenbogen BS
Mol Cell Endocrinol; 1999 Mar; 149(1-2):93-105. PubMed ID: 10375022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
